Dealing with downstream pain…
At 01 Oct 2007 14:17:17 in A-Team Insight Quarterly
Firms on both buy and sell sides want to do more OTC derivatives and structured products trading, and indeed in light of the credit crunch have had no choice but to do so. But how can they ensure that back office bottlenecks don’t put a brake on trading strategies?
By Thea George
The credit derivatives confirmations backlog that kicked off the past years’ focus on improving straight-through processing (STP) for OTC derivatives is somewhat old hat these days – or, more accurately, it was, until the “credit crunch” provoked a surge in volumes and back offices started to creak under the strain again.
Get A-Team IQ delivered to your desk free if you are a newsletter subscriber. Or click here to purchase a subscription.








